Medical use of artemisinin compounds and gephyrin agonists
US9999621B2 · kind B2 · utility
1Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2015 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Apr 9, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention refers to BTBD9 binders and gephyrin binders for medical use and in particular an artemisinin compound of general formula I for use in the treatment of a diabetes patient, as well as a method of identifying suitable lead candidates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.